BR112018068045A2 - método in vitro para identificar aneurismas da aorta torácica (taa) em um indivíduo - Google Patents

método in vitro para identificar aneurismas da aorta torácica (taa) em um indivíduo

Info

Publication number
BR112018068045A2
BR112018068045A2 BR112018068045A BR112018068045A BR112018068045A2 BR 112018068045 A2 BR112018068045 A2 BR 112018068045A2 BR 112018068045 A BR112018068045 A BR 112018068045A BR 112018068045 A BR112018068045 A BR 112018068045A BR 112018068045 A2 BR112018068045 A2 BR 112018068045A2
Authority
BR
Brazil
Prior art keywords
taa
thoracic aortic
vitro method
expression
identify
Prior art date
Application number
BR112018068045A
Other languages
English (en)
Portuguese (pt)
Inventor
Oller Pedrosa Jorge
Miguel Redondo Moya Juan
Ramón Campanero Garcia Miguel
Mendez-Barbero Nerea
Original Assignee
Centro Nac De Investigaciones Cardiovasculares Carlos Iii F S P
Consejo Superior Investigacion
Univ Madrid Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Nac De Investigaciones Cardiovasculares Carlos Iii F S P, Consejo Superior Investigacion, Univ Madrid Autonoma filed Critical Centro Nac De Investigaciones Cardiovasculares Carlos Iii F S P
Publication of BR112018068045A2 publication Critical patent/BR112018068045A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C12N9/0075—Nitric-oxide synthase (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96402—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals
    • G01N2333/96405—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general
    • G01N2333/96408—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general with EC number
    • G01N2333/96419—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/329—Diseases of the aorta or its branches, e.g. aneurysms, aortic dissection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112018068045A 2016-03-07 2016-12-30 método in vitro para identificar aneurismas da aorta torácica (taa) em um indivíduo BR112018068045A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382103 2016-03-07
PCT/EP2016/082925 WO2017153023A1 (en) 2016-03-07 2016-12-30 In vitro method for identifying thoracic aortic aneurysms (taa) in a subject

Publications (1)

Publication Number Publication Date
BR112018068045A2 true BR112018068045A2 (pt) 2019-01-08

Family

ID=55524277

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068045A BR112018068045A2 (pt) 2016-03-07 2016-12-30 método in vitro para identificar aneurismas da aorta torácica (taa) em um indivíduo

Country Status (8)

Country Link
US (2) US10907135B2 (https=)
EP (1) EP3427061B1 (https=)
JP (1) JP7057976B2 (https=)
AU (1) AU2016396401B2 (https=)
BR (1) BR112018068045A2 (https=)
CA (1) CA3017042C (https=)
ES (1) ES2965961T3 (https=)
WO (1) WO2017153023A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2555790B1 (es) 2014-06-05 2016-10-13 Consejo Superior De Investigaciones Científicas (Csic) Método de obtención de un array de micropartículas planares con multiplexado molecular superficial, array obtenido y su uso
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
ES2791415T3 (es) 2015-12-01 2020-11-04 Centro Nac De Investigaciones Cardiovasculares Carlos Iii F S P Método para diagnosticar miocardiopatías
CN111867622A (zh) 2017-11-24 2020-10-30 高等科学研究委员会（Csic） 经修饰的用于治疗布鲁氏菌病的布鲁氏菌疫苗株
WO2019161364A1 (en) * 2018-02-19 2019-08-22 The General Hospital Corporation Methods and compositions for the treatment of vascular disease
CN112752851B (zh) * 2018-07-27 2025-06-17 加利福尼亚大学董事会 胸主动脉瘤的生物标志物
US20230031371A1 (en) * 2020-01-10 2023-02-02 Deutsches Herzzentrum Muenchen Diagnosis of an aortic dissection by detecting a specific biomarker in a blood sample
US20210318336A1 (en) * 2020-04-09 2021-10-14 The Trustees Of The University Of Pennsylvania Methods for treating aortic aneurysm disease
WO2022219196A1 (en) * 2021-04-16 2022-10-20 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) Method for the diagnosis, prognosis and/or treatment of thoracic aortic aneurysm

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109522A1 (en) * 2001-09-24 2003-06-12 Manning Pamela T. Ophthalmologic treatment methods using selective iNOS inhibitors
US20150203916A1 (en) * 2012-06-27 2015-07-23 Music Foundation For Research Development Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
ES2555790B1 (es) 2014-06-05 2016-10-13 Consejo Superior De Investigaciones Científicas (Csic) Método de obtención de un array de micropartículas planares con multiplexado molecular superficial, array obtenido y su uso
ES2612340B1 (es) 2015-10-27 2018-03-09 Consejo Superior De Investigaciones Científicas (Csic) Sensor, aparato y procedimiento para la determinación de la concentración de solutos en disoluciones
ES2791415T3 (es) 2015-12-01 2020-11-04 Centro Nac De Investigaciones Cardiovasculares Carlos Iii F S P Método para diagnosticar miocardiopatías
WO2017187000A1 (es) 2016-04-29 2017-11-02 Universidad Autónoma de Madrid Formulaciones con sistemas lípidos portadores de compuestos bioactivos para su uso como agente adyuvante o potenciador de la terapia inmunológica en pacientes que sufren de cáncer o de transtornos inmunológicos
WO2017198717A1 (en) 2016-05-18 2017-11-23 Consejo Superior De Investigaciones Científicas Fusion proteins comprising an aldolase enzyme joined to a maltose binding protein
EP3681515A1 (en) 2017-09-15 2020-07-22 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Mafg as a potential therapeutic target to restore chemosensitivity in platinum-resistant cancer cells
EP3703756B1 (en) 2017-11-02 2022-04-20 Consejo Superior de Investigaciones Científicas (CSIC) Use of statins in overcoming resistance to beta-lactam antibiotics in bacterial species synthetizing isoprenoids using the mevalonate synthetic pathway
CN111867622A (zh) 2017-11-24 2020-10-30 高等科学研究委员会（Csic） 经修饰的用于治疗布鲁氏菌病的布鲁氏菌疫苗株
WO2019234189A1 (en) 2018-06-06 2019-12-12 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) Enhanced trained immunity in myeloid cells by ship-1 inhibition
JP7260341B2 (ja) 2019-03-06 2023-04-18 スタンレー電気株式会社 車両用灯具の制御装置、車両用灯具の制御方法、車両用灯具システム

Also Published As

Publication number Publication date
AU2016396401A1 (en) 2018-10-25
US10907135B2 (en) 2021-02-02
US20190112582A1 (en) 2019-04-18
JP2019510081A (ja) 2019-04-11
CA3017042A1 (en) 2017-09-14
EP3427061C0 (en) 2023-12-06
EP3427061A1 (en) 2019-01-16
AU2016396401B2 (en) 2023-07-13
ES2965961T3 (es) 2024-04-17
WO2017153023A1 (en) 2017-09-14
CA3017042C (en) 2024-02-20
US12163161B2 (en) 2024-12-10
JP7057976B2 (ja) 2022-04-21
US20210363501A1 (en) 2021-11-25
EP3427061B1 (en) 2023-12-06

Similar Documents

Publication Publication Date Title
BR112018068045A2 (pt) método in vitro para identificar aneurismas da aorta torácica (taa) em um indivíduo
MX2019009612A (es) Metodos de elaboracion de perfiles especificos al tipo celular para identificar objetivos de farmacos.
MX2021009682A (es) Biomarcadores de cinasa 2 dependientes de ciclinas y sus usos.
BR112017005730A2 (pt) predição de evento de risco cardiovascular e usos da mesma
WO2020087037A3 (en) Disease stratification of liver disease and related methods
BR112019006004A2 (pt) método e sistema para criação de um intervalo de referência personalizado, e, método para analisar associações clínicas.
BR112018074071A2 (pt) método e sistema para a determinação in ovo não destrutiva de sexo de ave
BR112017010190A2 (pt) sistema para medição de características, método de medição
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
EP4282405A3 (en) Detection of cancer biomarkers using nanoparticles
BR112017000875A2 (pt) sistemas e métodos para classificação de padrões de dados de resposta locais do sensor, representativos da gravidade da patologia da rede de distribuição
BR112018000012A2 (pt) sistema e método de avaliação de função endotelial
EA201992026A1 (ru) Применение биомаркеров при идентификации пациентов, имеющих рак, которые будут характеризоваться наличием восприимчивости к лечению ингибитором prmt5
BR112017004575A2 (pt) método de estimativa de comportamento atual ou futuro de uma entidade ou processo e aparelho para obter estimativas
BR112017025864A2 (pt) ?dispositivo para medir aspereza e brilho do cabelo, método para avaliar o estado do cabelo, kit e embalagem?
BR112022011676A2 (pt) Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método
BR112016017901A2 (pt) ensaio inovador para detectar periostina humana
BR112018012300A2 (pt) sistema, método e produto de programa de computador para medir características elétricas de biopartículas, e uso de um sistema
Knox et al. Using c-Jun to identify fear extinction learning-specific patterns of neural activity that are affected by single prolonged stress
WO2015166353A3 (en) Early detection of preeclampsia
Misuth et al. Estimation of PKCδ autophosphorylation in U87 MG glioma cells: Combination of experimental, conceptual and numerical approaches
Hong et al. Polarized mechanosensitive signaling domains protect arterial endothelial cells against inflammation
AR117708A1 (es) Procedimiento in vitro para la detección de disbiosis intestinal aviar
Hendricusdottir et al. F-dynamics: Automated quantification of dendrite filopodia dynamics in living neurons
BR112015000102A2 (pt) método de exibição de plano de fundo, dispositivo de exibição de plano de fundo e dispositivo eletrônico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements